Navigation Links
RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
Date:9/3/2014

995. Such statements include, but are not limited to, statements about future expectations, planned and future development of RXi Pharmaceuticals Corporation's products and technologies. Forward-looking statements about expectations and development plans of RXi's products involve significant risks and uncertainties:  the risk that we may not be able to successfully develop our candidates, or that development of RNAi-based therapeutics may be delayed or not proceed as planned, or that we may not develop any RNAi-based products; risks that the development process for our product candidates may be delayed, risks related to the development and commercialization of products by our competitors, the risk related to our ability to control the timing and terms of collaborations with third parties, and the possibility that other companies or organizations may assert patent rights preventing us from developing our products. Actual results may differ from those contemplated by these forward-looking statements. RXi does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release.

Contact
RXi Pharmaceuticals Corporation
Tamara McGrillen
508-929-3646
tmcgrillen@rxipharma.com


'/>"/>
SOURCE RXi Pharmaceuticals Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , December 17, 2014 ... less than a hub of information concerning the biopharmaceutical Group,s ... A further addition to the recently launched institutional website ... has now been enriched by a new chapter in the ... A richly detailed and panoramic hub on the world ...
(Date:12/17/2014)... 2014 PCCA received the Autism Hope ... ) program seal for best practices in meeting ... medical practices, materials and goods that meet strict ... Children affected by autism often have unique physical ... ingredients found in food and medicine – for ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of ... Forecasts, 2012-2018"  report to their offering. Global Guidewires ... The North America accounts for ... Europe claims approximately 25% (2018). ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4
... International, Inc. (NYSE: VRX ) (TSX: VRX) ... its wholly owned indirect subsidiary, launched its offer of ... notes (the "Notes"). The Notes will not ... amended (the "Securities Act"), or any state securities law ...
... ALISO VIEJO, Calif., Feb. 3, 2011 A VANIR ... reported unaudited financial results for the three months ended December 31, ... reported a net loss of $12.1 million, or $0.11 loss per ... loss per share, for the same period in fiscal 2010. Net ...
Cached Medicine Technology:Valeant Launches Senior Notes Offering 2Valeant Launches Senior Notes Offering 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 2AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 3AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 4AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 5AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results 6
(Date:12/19/2014)... Hands On Mobile Spa, has announced they now ... Wheels has been transformed into a utopia for the Long ... to disappear. The Virtual Tour showcases the beauty of the ... events and more. , The Virtual Tour shows viewers each ... actually an overhauled Winnebago. Marla Kaplan-Pelle, Director states " It's ...
(Date:12/19/2014)... 19, 2014 After a 13-year absence ... again returning to the stage to entertain his many ... concert performances, and the successful tour has been steadily ... , Visit Ticketability.com for a large ... shows at fair prices. , Music fans have had ...
(Date:12/19/2014)... new study suggests a possible link between certain menopause ... sweats -- and higher rates of hip fractures and ... affecting about 60 percent of women. The hormonal changes ... then face a higher risk of weakened bones and ... or severe menopausal symptoms are more likely to have ...
(Date:12/19/2014)... 18, 2014 (HealthDay News) -- Prostaglandin analogue eye drops ... reduce the risk of vision loss in patients with ... researchers led by David Garway-Heath, of the Moorfields Eye ... outcomes for more than 500 people newly diagnosed with ... disease and one of the leading causes of blindness. ...
(Date:12/17/2014)... This prestigious award is given ... made outstanding and innovative contributions to the physical ... private practice physical therapy by the Private Practice ... On behalf of Performance Physical Therapy, Michelle Collie ... Performance accepted the award at the Private Practice, ...
Breaking Medicine News(10 mins):Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2
... HOLMDEL, N.J., Sept. 11 Sparta Systems, ... market leader in enterprise quality and,compliance management ... company specializing in the safety evaluation of ... and improve operational,control. The go-live implementation, including ...
... target for treatment, reseachers say , TUESDAY, Sept. 11 ... schizophrenia, researchers believe they may have found the disease,s ... could lead to the development of better treatments, the ... developed a mouse model for schizophrenia by inserting the ...
... Looking at more than 500 reports, including toxicological, clinical ... the latest studies on the high-intensity sweetener, along with ... from 10 universities and medical schools evaluated the safety ... a variety of health conditions. Their study is published ...
... HOUSTON, Sept. 11 Natural Nutrition, Inc.,(OTC ... Waples, champion,fitness model and athlete, has signed ... Natural Nutrition,s new international direct marketing campaign.,Natural ... of nutritional products that,will be directly marketed ...
... The Netherlands, September 11 According to a,recently ... function. This study is the first study investigating ... brain function. It was also found that,frequent mobile ... be,explained as a learning effect related to making ...
... Survival rates for,U.S. hospital inpatients have improved since ... the increased severity of the illnesses being,treated, according ... Healthcare,Improvement (NYSE: TOC ; TSX: TOC). ... 1998-,2006," advances in care realized by U.S. hospitals ...
Cached Medicine News:Health News:NAMSA Deploys TrackWise Software as its Quality Management System 2Health News:Schizophrenia Gene May Have On/Off Switch 2Health News:Aspartame is safe, study says 2Health News:Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign 2Health News:'Slowed Brain-Activity' in Frequent Mobile Phone Users 2Health News:Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows 2Health News:Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows 3
... tubes contain a buffered sodium ... with a citrate concentration of ... mol/l (3.8%). The mixing ratio ... to 9 parts blood. In ...
... Cross-match tubes are available in ... tube contains a clotting activator ... tests where serum is required ... cross-match tube is suitable where ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® spray-coated K2EDTA tubes are used for whole blood hematology determinations and immunohematology testing....
Medicine Products: